The Influence of Long-Term Supplementation with Lactiplantibacillus plantarum LP28 on NK Cell Activity and Upper Respiratory Symptoms in Middle-Aged and Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Population aging and immunosenescence pose immense challenges to healthcare systems by increasing susceptibility to infections. Lactiplantibacillus plantarum LP28 ( L. plantarum LP28) is a strain isolated from traditional Taiwanese dried tofu with significant immunomodulatory potential.

Objective

To evaluate the clinical efficacy of long-term L. plantarum LP28 supplementation in common cold prevention and its effect on systemic immune biomarkers in middle-aged and elderly individuals.

Methods

In this 12-week, randomized, double-blind, placebo-controlled trial, 102 middle-aged and older adults (aged 50–75 years) were assigned to receive an oral probiotic (5 × 10 9 CFU L. plantarum LP28/capsule, two capsules daily; n = 51) or a placebo ( n = 51). Cold incidence and symptom severity were evaluated by the Wisconsin Upper Respiratory Symptom Survey (WURSS). Immune cell populations, serum/salivary markers, and natural killer (NK) cell activity were quantified using flow cytometry, ELISAs and NK cell cytotoxicity assays, respectively. The data were analyzed using a refined per-protocol approach and outlier-removed sensitivity analyses to ensure robustness. Independent t tests, chi-square/Fisher’s exact tests, and Mann – Whitney U tests were used for statistical comparisons.

Results

The probiotic group exhibited a notable reduction in cold incidence (34.78% vs. 52.00% in the placebo group) and a lower cumulative symptom burden. In terms of immunomodulatory effects, L. plantarum LP28 supplementation significantly increased serum interleukin (IL)-12 levels and NK cell cytotoxicity, reinforcing innate immune defense through the activation of the IL-12/NK cell axis. This was accompanied by a significant reduction in the level of the inflammatory marker C-reactive protein (CRP).

Conclusions

L. plantarum LP28 supplementation serves as an effective supportive strategy for promoting healthy aging by increasing respiratory defense resilience and mitigating systemic inflammatory stress through pleiotropic immune modulation.

Clinical Trial Registration

This trial was registered at ClinicalTrials.gov under the registration number NCT06724185 ( https://clinicaltrials.gov/study/NCT06724185 ).

Article activity feed